Top

Quality of Life Research

Gepubliceerd in:

13-12-2022

Pre-treatment quality of life in patients with salivary gland cancer in comparison with those of head and neck cancer patients

Auteurs: Danbee Kang, Eunhye Kim, Nayeon Choi, HeeJung Kim, Juhee Cho, Han-Sin Jeong

Gepubliceerd in: Quality of Life Research | Uitgave 5/2023

Abstract

Introduction

Salivary gland cancer (SGC) is a rare malignant tumor arising from the salivary glands, with a variety of clinical and biological behaviors different from head and neck cancer (HNC). Because of the rarity of SGC, there are limited data on pre-treatment quality of life (QoL). Therefore, we evaluated the pre-treatment QoL in SGC patients by stage and compared it with that of HNC patients.

Methods

From a prospective registry of HNC patients (2016–2020), we selected 225 patients with SGC, and 912 patients with oral cavity (OC) and oropharyngeal cancer (OPC) who were diagnosed in the same period as the HNC control group. The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) and HNC-Specific Module (H&N35) were used to assess QoL.

Results

SGC patients had a statistically better baseline QoL (69.8 vs. 64.0), emotional (82.1 vs. 78.8), cognitive (92.0 vs. 88.7), and social function (86.3 vs. 80.5), and fewer symptoms than HNC patients. The estimated average QoL differences between SGC patient diagnosed at stages I and IV was −12.9. Especially, advanced-stage of tumors was associated with much lower role functioning and emotional functioning scores in SGC patients, compared to those in HNC patients, among females and of younger age.

Discussion

Although the overall QoL score was higher in SGC patients than in HNC patients, specific domains were significantly affected in SGC patients according to the tumor stage. Females and those of younger age were more affected by severity of disease in SGC.

Study registration: ClinicalTrials.gov Identifier NCT02546895.

vorige artikel Do mothers or females without children have better health-related quality of life across their reproductive years?

volgende artikel Predictors of change in asthma-related quality of life: a longitudinal real-life study in adult asthmatics

Alleen toegankelijk voor geautoriseerde gebruikers

Del Signore, A. G., & Megwalu, U. C. (2017). The rising incidence of major salivary gland cancer in the United States. Ear, Nose, and Throat Journal, 96(3), E13–E16.CrossRefPubMed

Pinkston, J. A., & Cole, P. (1999). Incidence rates of salivary gland tumors: Results from a population-based study. Otolaryngology—Head and Neck Surgery, 120(6), 834–840.CrossRefPubMed

Fu, J. Y., Wu, C. X., Shen, S. K., Zheng, Y., Zhang, C. P., & Zhang, Z. Y. (2019). Salivary gland carcinoma in Shanghai (2003–2012): An epidemiological study of incidence, site and pathology. BMC Cancer, 19(1), 350.CrossRefPubMedPubMedCentral

Bradley, P. J., & McGurk, M. (2013). Incidence of salivary gland neoplasms in a defined UK population. British Journal of Oral and Maxillofacial Surgery, 51(5), 399–403.CrossRefPubMed

Geiger, J. L., Ismaila, N., Beadle, B., Caudell, J. J., Chau, N., Deschler, D., et al. (2021). Management of Salivary Gland Malignancy: ASCO Guideline. Journal of Clinical Oncology, 39(17), 1909–1941.CrossRefPubMed

Haslam, A., Herrera-Perez, D., Gill, J., & Prasad, V. (2020). Patient experience captured by quality-of-life measurement in oncology clinical trials. JAMA Network Open, 3(3), e200363.CrossRefPubMedPubMedCentral

Joly, F., Vardy, J., Pintilie, M., & Tannock, I. F. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18(12), 1935–1942.CrossRefPubMed

Roila, F., & Cortesi, E. (2001). Quality of life as a primary end point in oncology. Annals of Oncology, 12(Suppl 3), S3-6.CrossRefPubMed

Stenner, M., Beenen, F., Hahn, M., Koopmann, M., Weiss, D., & Huttenbrink, K. B. (2016). Exploratory study of long-term health-related quality of life in patients with surgically treated primary parotid gland cancer. Head and Neck, 38(1), 111–117.CrossRefPubMed

10.

Becker, C., Pfeiffer, J., Lange, K., & Dahlem, K. K. K. (2018). Health-related quality of life in patients with major salivary gland carcinoma. European Archives of Oto-Rhino-Laryngology, 275(4), 997–1003.CrossRefPubMed

11.

Al-Mamgani, A., van Rooij, P., Verduijn, G. M., Meeuwis, C. A., & Levendag, P. C. (2012). Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center. International Journal of Radiation Oncology Biology Physics, 84(1), 189–195.CrossRefPubMed

12.

Steffens, D., Solomon, M., Vuong, K., Alchin, L., Roberts, R., Koh, C., et al. (2018). Effect of timing on baseline quality of life scores among surgical cancer patients. BMC Research Notes, 11(1), 210.CrossRefPubMedPubMedCentral

13.

van Leeuwen, M., Husson, O., Alberti, P., Arraras, J. I., Chinot, O. L., Costantini, A., et al. (2018). Understanding the quality of life (QOL) issues in survivors of cancer: Towards the development of an EORTC QOL cancer survivorship questionnaire. Health and Quality of Life Outcomes, 16(1), 114.CrossRefPubMedPubMedCentral

14.

Karvonen-Gutierrez, C. A., Ronis, D. L., Fowler, K. E., Terrell, J. E., Gruber, S. B., & Duffy, S. A. (2008). Quality of life scores predict survival among patients with head and neck cancer. Journal of Clinical Oncology, 26(16), 2754–2760.CrossRefPubMed

15.

Jin, H., Kim, B. Y., Kim, H., Lee, E., Park, W., Choi, S., et al. (2019). Incidence of postoperative facial weakness in parotid tumor surgery: A tumor subsite analysis of 794 parotidectomies. BMC Surgery, 19(1), 199.CrossRefPubMedPubMedCentral

16.

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.CrossRefPubMed

17.

Bjordal, K., de Graeff, A., Fayers, P. M., Hammerlid, E., van Pottelsberghe, C., Curran, D., et al. (2000). A 12 country field study of the EORTC QLQ-C30 (version 30) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients EORTC Quality of Life Group. European Journal of Cancer, 36(14), 1796–1807.CrossRefPubMed

18.

Yun, Y. H., Bae, S. H., Kang, I. O., Shin, K. H., Lee, R., Kwon, S. I., et al. (2004). Cross-cultural application of the Korean version of the European organization for research and treatment of cancer (EORTC) breast-cancer-specific quality of life questionnaire (EORTC QLQ-BR23). Supportive Care in Cancer, 12(6), 441–445.CrossRefPubMed

19.

Fayers, P. M., Aaronson, N. K., & Bjordal, K. (2001). The EORTC QLQ-C30 Scoring Manual (3rd ed.). European Organization for Research and Treatment of Cancer.

20.

Cocks, K., King, M. T., Velikova, G., Fayers, P. M., & Brown, J. M. (2008). Quality, interpretation and presentation of European organisation for research and treatment of cancer quality of life questionnaire core 30 data in randomised controlled trials. European Journal of Cancer, 44(13), 1793–1798.CrossRefPubMed

21.

Park, S. I., Park, W., Choi, S., Jang, Y., Kim, H., Kim, S. H., et al. (2020). Clinical outcome of minor salivary gland cancers in the oral cavity: A comparative analysis with squamous cell carcinomas of the oral cavity. Frontiers in Oncology, 10, 881.CrossRefPubMedPubMedCentral

22.

Hammerlid, E., Adnan, A., & Silander, E. (2017). Population-based reference values for the European organization for research and treatment of cancer head and neck module. Head and Neck, 39(10), 2036–2047.CrossRefPubMed

23.

Hamilton, S. N., Tran, E., Ho, C., Berthelet, E., Wu, J., DeVries, K., et al. (2021). Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer. Supportive Care in Cancer, 29(5), 2537–2547.CrossRefPubMed

24.

Hammerlid, E., Bjordal, K., Ahlner-Elmqvist, M., Boysen, M., Evensen, J. F., Biorklund, A., et al. (2001). A prospective study of quality of life in head and neck cancer patients Part I: At diagnosis. The Laryngoscope, 111(4 Pt 1), 669–680.CrossRefPubMed

25.

Gyori, E., Przestrzelski, C., Pona, I., Hagmann, M., Rath, T., Radtke, C., et al. (2018). Quality of life and functional assessment of facial palsy patients: A questionnaire study. International Journal of Surgery, 55, 92–97.CrossRefPubMed

26.

Ho, A. L., Scott, A. M., Klassen, A. F., Cano, S. J., Pusic, A. L., & Van Laeken, N. (2012). Measuring quality of life and patient satisfaction in facial paralysis patients: A systematic review of patient-reported outcome measures. Plastic and Reconstructive Surgery, 130(1), 91–99.CrossRefPubMed

27.

Choi, S. Y., Lee, E., Kim, E., Chung, M. K., Son, Y. I., Baek, C. H., et al. (2021). Clinical outcomes of bulky parotid gland cancers: Need for self-examination and screening program for early diagnosis of parotid tumors. BMC Cancer, 21(1), 178.CrossRefPubMedPubMedCentral

28.

Liao, L. J., Hsu, W. L., Lo, W. C., Cheng, P. W., Shueng, P. W., & Hsieh, C. H. (2019). Health-related quality of life and utility in head and neck cancer survivors. BMC Cancer, 19(1), 425.CrossRefPubMedPubMedCentral

29.

Weymuller, E. A., Yueh, B., Deleyiannis, F. W., Kuntz, A. L., Alsarraf, R., & Coltrera, M. D. (2000). Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients. Archives of Otolaryngology–Head & Neck Surgery, 126(3), 329–335.CrossRef

30.

Babin, E., Sigston, E., Hitier, M., Dehesdin, D., Marie, J. P., & Choussy, O. (2008). Quality of life in head and neck cancers patients: Predictive factors, functional and psychosocial outcome. European Archives of Oto-Rhino-Laryngology, 265(3), 265–270.CrossRefPubMed

31.

de Graeff, A., de Leeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. (2001). Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. European Journal of Cancer, 37(3), 332–339.CrossRefPubMed

32.

Sutherland, H. J., & Till, J. E. (1993). Quality of life assessments and levels of decision making: Differentiating objectives. Quality of Life Research, 2(4), 297–303.CrossRefPubMed

Titel: Pre-treatment quality of life in patients with salivary gland cancer in comparison with those of head and neck cancer patients
Auteurs: Danbee Kang
Eunhye Kim
Nayeon Choi
HeeJung Kim
Juhee Cho
Han-Sin Jeong
Publicatiedatum: 13-12-2022
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 5/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-022-03323-8

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Introduction

Methods

Results

Discussion

Log in om toegang te krijgen

Andere artikelen Uitgave 5/2023

Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata

Inferring meaningful change in quality of life with posterior predictive distribution: an alternative to standard error of measurement

“From Where I Stand”: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ)

Lived experience of patients with sleep apnea: a systematic synthesis of qualitative evidence

Do mothers or females without children have better health-related quality of life across their reproductive years?

Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks